Scyllo-Inositol-d6

Scyllo-Inositol-d6 is the deuterium labeled Scyllo-Inositol. Scyllo-Inositol is an inhibitor that targets the aggregation of misfolded proteins (such as α-synuclein and Amyloid-β), is orally effective, and can cross the blood-brain barrier. Scyllo-Inositol can selectively bind to and stabilize non-toxic oligomers, preventing them from converting into toxic fibers, exerting protein homeostasis regulation and neuroprotective activity. Scyllo-Inositol binds to the hydrophobic region of pathogenic proteins, inhibits protein aggregation, and promotes lysosome- and proteasome-mediated degradation pathways, thereby reducing neurotoxicity. Scyllo-Inositol can be used in the study of neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, and Huntington's disease[1][2][3].

115268-26-3

12352211

Amyloid-β; Isotope-Labeled Compounds; α-synuclein

Neuronal Signaling; Others

Neurological Disease

[2H][C@]1([C@@]([2H])(O)[C@]([2H])(O)[C@@](O)([C@@]([2H])([C@]1(O)[2H])O)[2H])O

C6H6D6O6

186.19

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-W707693/

Isotope-Labeled Compounds

No Development Reported